Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sivelestat Treatment for Postoperative Organ Protection in Type A Aortic Dissection	Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, multiple organ dysfunction syndrome	Not yet recruiting	Phase 4	2025-09-05		NCT07156656

7 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Changhai Hospital	141
First Affiliated Hospital Xi'an Jiaotong University	142
Fujian Provincial Hospital	45
Guangdong Provincial People's Hospital	164
Shanghai Zhongshan Hospital	347
The First Affiliated Hospital of Anhui Medical University	85
The University of Hong Kong-Shenzhen Hospital	27

6 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Changhai Hospital of Shanghai	Shanghai	China	4
Fujian Provincial Hospital	Fuzhou	China	14
Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences) (Guangdong Provincial People's Hospital Affiliated to Southern Medical University)	Guangzhou	China	1
The First Affiliated Hospital of Anhui Medical University	Hefei	China	44
The First Affiliated Hospital of Xi'an Jiao Tong University	Xi'an	China	6
The University of Hong Kong - Shenzhen Hospital	Shenzhen	China	4